All research
2026-06-29 PubMed

YAP/TAZ signaling and ECM dynamics integrate mechanobiology with metabolic reprogramming across organ systems

Mechanobiology-Driven Metabolic Reprogramming: Integrative Roles of YAP/TAZ Signaling and Extracellular Matrix Dynamics.

Background

The intricate link between physical forces and cellular metabolism, known as mechanobiology, is crucial for transcriptional, metabolic, and epigenetic adaptations. However, the precise mechanisms by which extracellular matrix (ECM) dynamics and mechanotransduction pathways orchestrate metabolic reprogramming in both healthy and diseased states remain largely undefined. Understanding this coordination is vital, as dysregulation contributes to conditions like cardiovascular remodeling, fibrosis, and metabolic disease. This review addresses this gap by proposing an integrative framework centered on the YAP/TAZ signaling axis.

Study Design

This comprehensive review synthesized current literature to establish a focused mechanometabolic framework. It integrated findings across cardiovascular, skeletal, and endocrine systems, emphasizing the convergence of ECM remodeling, cytoskeletal tension, and force-dependent signaling pathways. The authors critically examined the role of the YAP/TAZ signaling axis as a central mechanosensitive transcriptional regulator. They also explored how aberrant mechanotransduction contributes to various pathologies and discussed emerging evidence linking viscoelasticity, mitochondrial dynamics, and immunometabolism to disease progression and therapeutic responses.

Results

The review positions the YAP/TAZ signaling axis as a key mechanosensitive transcriptional regulator, acting downstream of integrin-focal adhesion kinase (FAK)-Src, RhoA/ROCK, actomyosin tension, and both Hippo-dependent and Hippo-independent signaling networks. This axis directly influences metabolic programs, including glycolysis, mitochondrial function, redox homeostasis, and anabolic biosynthesis. Key downstream targets identified include GLUT1, HK2, and PFKFB3, which are critical for glucose metabolism. Aberrant mechanotransduction, often involving dysregulated YAP/TAZ activity, was shown to contribute significantly to cardiovascular remodeling, endothelial dysfunction, and fibrosis. The review also highlighted the context-dependent roles of YAP/TAZ in mediating adaptive versus pathological responses. > In skeletal metabolism, the gut-bone axis was presented as a bidirectional mechanochemical network, where microbiota-derived metabolites, osteoimmune signaling, and biomechanical loading collectively regulate bone remodeling and systemic metabolism.

Key Findings

  • YAP/TAZ signaling acts as a central mechanosensitive transcriptional regulator integrating physical forces with metabolic programs.
  • YAP/TAZ influences glycolysis, mitochondrial function, redox homeostasis, and anabolic biosynthesis via targets like GLUT1, HK2, PFKFB3.
  • Aberrant mechanotransduction, often involving YAP/TAZ, contributes to cardiovascular remodeling, endothelial dysfunction, and fibrosis.
  • The gut-bone axis functions as a mechanochemical network regulating bone and systemic metabolism.
  • Context-dependent roles of YAP/TAZ determine adaptive versus pathological metabolic responses.

Why It Matters

This integrative framework significantly advances our understanding of how mechanical cues influence cellular metabolism, offering new perspectives on disease pathogenesis. Targeting the YAP/TAZ axis or ECM dynamics could represent novel therapeutic strategies for a range of conditions, including cardiovascular disease, fibrosis, and metabolic disorders. For biohackers and clinicians, this highlights the profound impact of physical activity, tissue mechanics, and even gut health on systemic metabolic regulation. While not a direct protocol, it underscores the importance of considering mechanobiological factors in disease prevention and treatment, suggesting future avenues for interventions that modulate cellular energetics through mechanical means, potentially via advanced mechanobiomaterials.


mechanobiology yap-taz metabolic-reprogramming extracellular-matrix cardiovascular-disease fibrosis
Source: pubmed:42370757 · Ingested 2026-06-29 · Digest: gemini-2.5-flash